Taysha Gene Therapies
TSHA
#5447
Rank
โ‚น124.56 B
Marketcap
โ‚น454.75
Share price
2.86%
Change (1 day)
224.39%
Change (1 year)

Market capitalization of Taysha Gene Therapies (TSHA)

Market cap: โ‚น124.56 Billion

As of January 2026 Taysha Gene Therapies has a market cap of โ‚น124.56 Billion. This makes Taysha Gene Therapies the world's 5447th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Taysha Gene Therapies from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น124.56 B-13.11%
2025โ‚น143.35 B365.94%
2024โ‚น30.76 B11.68%
2023โ‚น27.54 B135.91%
2022โ‚น11.67 B-65%
2021โ‚น33.36 B-54.48%
2020โ‚น73.29 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Taysha Gene Therapies was reported to be:

โ‚น124.56 Billion
by Nasdaq info icon info icon
โ‚น124.56 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
โ‚น98.85 B-20.64%๐Ÿ‡บ๐Ÿ‡ธ USA